🇺🇸 FDA
Pipeline program

CHLORURE DE SODIUM 0,9% RENAUDIN, solution injectable, VENLAFAXINE, KETAMINE , 11C-UCB-J

APHP220668

Phase 3 small_molecule active

Quick answer

CHLORURE DE SODIUM 0,9% RENAUDIN, solution injectable, VENLAFAXINE, KETAMINE , 11C-UCB-J for Major depressive disorder with current severe major depressive episode is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Major depressive disorder with current severe major depressive episode
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials